Holen Sie sich die Stockscreener-App
4.13
3.97%
-0.04
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
HCW Biologics (NASDAQ:HCWB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
HCW Biologics Sees Strong Investor Interest in June - TipRanks
HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Down 85.9% in May - Defense World
HCW Biologics (NASDAQ:HCWB) Trading Down 7.6% – Here’s What Happened - Defense World
Wall Street Zen Upgrades HCW Biologics (NASDAQ:HCWB) to “Hold” - Defense World
HCW Biologics Meets Nasdaq Listing Requirements in May 2025 - TipRanks
HCW Biologics partners with WY Biotech for immunotherapy By Investing.com - Investing.com South Africa
HCW Biologics Secures Licensing Agreement with WY Biotech - TipRanks
HCW Biologics partners with WY Biotech for immunotherapy - Investing.com Australia
HCW Biologics (HCWB) Secures $7M Upfront License Fee in New Agreement with WY Biotech | HCWB Stock News - GuruFocus
HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech - GlobeNewswire
HCW Biologics Engages Armistice in Securities Purchase - TipRanks
HCW Biologics (NASDAQ:HCWB) Price Target Lowered to $35.00 at Maxim Group - Defense World
HCW Biologics (HCWB) Price Target Adjusted by Maxim | HCWB Stock News - GuruFocus
HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HC - GuruFocus
HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HCWB Stock News - GuruFocus
HCW Biologics Issues Shares Through Warrant Exercise - TipRanks
Insider Buying: Hing Wong Acquires Additional Shares of HCW Biol - GuruFocus
HCW Biologics Enters Securities Purchase Agreement - TipRanks
HCW Biologics (NASDAQ:HCWB) Trading 9.1% Higher – Still a Buy? - Defense World
HCW Biologics Inc Reports Q1 2025 Earnings: Revenue at $5,065, Net Loss Reduced to $2.2 Million - GuruFocus
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - The Manila Times
HCW Biologics Inc. Reports Q1 2025 Financial Results and $5 Million Equity Offering Completion - Nasdaq
HCW Biologics Closes $5 Million Public Offering - TipRanks
HCW Biologics (HCWB) Launches $5M Follow-On Offering - GuruFocus
HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - The Manila Times
HCW Biologics Raises Fresh Capital: $5M Follow-On Offering Includes Attractive Warrant Package - Stock Titan
HCWB Announces Maxim Group LLC as Sole Placement Agent for Offer - GuruFocus
HCWB Announces Maxim Group LLC as Sole Placement Agent for Offering | HCWB Stock News - GuruFocus
Three layers of uncertainty - The Globe and Mail
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Trading Halt for HCW Biologics (HCWB) Due to Volatility | HCWB S - GuruFocus
Trading Resumes for HCW Biologics (HCWB) | HCWB Stock News - GuruFocus
HCW Biologics Reports Positive Results For HCW9206 And Opens Commercial Partnership Talks - Nasdaq
HCW Biologics Says Studies Show HCW9206 Fusion Protein Addresses Key Challenges for CAR-T Therapies; Shares Surge - marketscreener.com
HCW Biologics (HCWB) Unveils Innovative Pathway for Enhanced CAR - GuruFocus
HCW Biologics presents novel CAR-T cell enhancer By Investing.com - Investing.com Nigeria
HCW Biologics presents novel CAR-T cell enhancer - Investing.com
HCW Biologics Announces Positive Results of Studies of - GlobeNewswire
HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization - TradingView
Friday’s Insider Moves: Top Buys and Sells in US Stocks Revealed By Investing.com - Investing.com South Africa
Friday’s Insider Moves: Top Buys and Sells in US Stocks Revealed - Investing.com
Prediction: Warren Buffett May Be Shifting Out of His Berkshire Hathaway CEO Role, but He's Not Done Investing - The Globe and Mail
Should You Buy Rivian Stock While It Is Still Below $15? - The Globe and Mail
This Well-Known Toy Company Is Set to Be an Outperformer if the Tariff War Continues - The Globe and Mail
Insider Buying: Gary Winer Acquires Shares of HCW Biologics Inc (HCWB) - GuruFocus
Hcw biologics CEO acquires $2.41 million in stock By Investing.com - Investing.com Nigeria
0.34%
7.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):